Lymphoedema home page: Diagnosis, Treatment and Care


exp date isn't null, but text field is

These pathways and guidelines are designed to support the diagnosis, investigation and management of people with lymphoedema and chronic oedema.

Lymphoedema is swelling primarily due to lymphatic insufficiency. This may be an inherited or congenital primary lymphoedema, or an acquired lymphoedema that is secondary to cancer treatment, or non-cancer causes including surgery and infection.

Some individuals develop chronic swelling that starts with a non-lymphatic cause. Several factors may contribute to a sustained increase in interstitial fluid, overwhelming and compromising the lymphatic system, often leading to lymphoedema, and delayed wound healing.

These pathways and clinical guidelines were developed by a collaborative process involving NHS Highland professionals from vascular services, dermatology, oncology, pharmacy and microbiology; along with people living with lymphoedema. This was undertaken as part of the Highland Lymphoedema Project, between 2012 and 2014. Comments are welcome.



Last reviewed: 30 April 2021

Next review: 30 April 2023

Author(s): Highland Lymphoedema Service

Version: 1

Approved By: TAM subgroup of ADTC

Reviewer Name(s): Advanced Lymphoedema Nurse

Document Id: TAM228

Internal URL: